Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597831489> ?p ?o ?g. }
- W2597831489 endingPage "39086" @default.
- W2597831489 startingPage "39077" @default.
- W2597831489 abstract "MLAA-34 is a newly identified monocytic leukemia-associated antigen that is overexpressed in acute monocytic leukemia specifically, thus providing a novel target for the therapy of acute monocytic leukemia. In this study, we first expressed MLAA-34 protein in Escherichia coli (E.coli) BL21 (DE3) cells and purified it by nickel ion affinity chromatography with high purity (>90%). Then, MLAA-34 was used as antigen for biopanning anti-MLAA-34 single chain antibody fragment (ScFv) from a fully human ScFv library, and a high affinity ScFv named MA1 was selected by phage-ELISA. Finally, after expression of MA1, we found that MA1 can specifically bind with U937 MLAA-34 positive cells, and the binding affinity of MA1 was at the nanomolar level. Furthermore, inhibition of U937 cell proliferation indicated that the novel antibody MA1 has the potential to be used as a therapeutic agent for acute monocytic leukemia." @default.
- W2597831489 created "2017-04-07" @default.
- W2597831489 creator A5003759585 @default.
- W2597831489 creator A5016890292 @default.
- W2597831489 creator A5022438900 @default.
- W2597831489 creator A5022802322 @default.
- W2597831489 creator A5026828904 @default.
- W2597831489 creator A5037831830 @default.
- W2597831489 creator A5089363242 @default.
- W2597831489 date "2017-03-28" @default.
- W2597831489 modified "2023-10-01" @default.
- W2597831489 title "Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology" @default.
- W2597831489 cites W1531785323 @default.
- W2597831489 cites W1586085231 @default.
- W2597831489 cites W1834944463 @default.
- W2597831489 cites W1964592316 @default.
- W2597831489 cites W1968949976 @default.
- W2597831489 cites W1976439451 @default.
- W2597831489 cites W1978659582 @default.
- W2597831489 cites W1988785438 @default.
- W2597831489 cites W1989639228 @default.
- W2597831489 cites W2008957139 @default.
- W2597831489 cites W2017559786 @default.
- W2597831489 cites W2052332203 @default.
- W2597831489 cites W2066637625 @default.
- W2597831489 cites W2073142661 @default.
- W2597831489 cites W2076426515 @default.
- W2597831489 cites W2084262669 @default.
- W2597831489 cites W2087762900 @default.
- W2597831489 cites W2088332148 @default.
- W2597831489 cites W2127673711 @default.
- W2597831489 cites W2132912591 @default.
- W2597831489 cites W2140838421 @default.
- W2597831489 cites W2144210827 @default.
- W2597831489 cites W2161879531 @default.
- W2597831489 cites W2252299908 @default.
- W2597831489 cites W2256354870 @default.
- W2597831489 cites W2272640237 @default.
- W2597831489 cites W2273204150 @default.
- W2597831489 cites W2279609854 @default.
- W2597831489 cites W2318669237 @default.
- W2597831489 cites W2400457897 @default.
- W2597831489 cites W2503928099 @default.
- W2597831489 cites W2551291014 @default.
- W2597831489 cites W4211077138 @default.
- W2597831489 doi "https://doi.org/10.18632/oncotarget.16590" @default.
- W2597831489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5503596" @default.
- W2597831489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28388565" @default.
- W2597831489 hasPublicationYear "2017" @default.
- W2597831489 type Work @default.
- W2597831489 sameAs 2597831489 @default.
- W2597831489 citedByCount "2" @default.
- W2597831489 countsByYear W25978314892017 @default.
- W2597831489 countsByYear W25978314892022 @default.
- W2597831489 crossrefType "journal-article" @default.
- W2597831489 hasAuthorship W2597831489A5003759585 @default.
- W2597831489 hasAuthorship W2597831489A5016890292 @default.
- W2597831489 hasAuthorship W2597831489A5022438900 @default.
- W2597831489 hasAuthorship W2597831489A5022802322 @default.
- W2597831489 hasAuthorship W2597831489A5026828904 @default.
- W2597831489 hasAuthorship W2597831489A5037831830 @default.
- W2597831489 hasAuthorship W2597831489A5089363242 @default.
- W2597831489 hasBestOaLocation W25978314891 @default.
- W2597831489 hasConcept C104317684 @default.
- W2597831489 hasConcept C104428545 @default.
- W2597831489 hasConcept C108634530 @default.
- W2597831489 hasConcept C153911025 @default.
- W2597831489 hasConcept C159654299 @default.
- W2597831489 hasConcept C167625842 @default.
- W2597831489 hasConcept C186268636 @default.
- W2597831489 hasConcept C203014093 @default.
- W2597831489 hasConcept C204258353 @default.
- W2597831489 hasConcept C2776170302 @default.
- W2597831489 hasConcept C2776471321 @default.
- W2597831489 hasConcept C2778461978 @default.
- W2597831489 hasConcept C2780943621 @default.
- W2597831489 hasConcept C502942594 @default.
- W2597831489 hasConcept C54355233 @default.
- W2597831489 hasConcept C55493867 @default.
- W2597831489 hasConcept C81885089 @default.
- W2597831489 hasConcept C86803240 @default.
- W2597831489 hasConceptScore W2597831489C104317684 @default.
- W2597831489 hasConceptScore W2597831489C104428545 @default.
- W2597831489 hasConceptScore W2597831489C108634530 @default.
- W2597831489 hasConceptScore W2597831489C153911025 @default.
- W2597831489 hasConceptScore W2597831489C159654299 @default.
- W2597831489 hasConceptScore W2597831489C167625842 @default.
- W2597831489 hasConceptScore W2597831489C186268636 @default.
- W2597831489 hasConceptScore W2597831489C203014093 @default.
- W2597831489 hasConceptScore W2597831489C204258353 @default.
- W2597831489 hasConceptScore W2597831489C2776170302 @default.
- W2597831489 hasConceptScore W2597831489C2776471321 @default.
- W2597831489 hasConceptScore W2597831489C2778461978 @default.
- W2597831489 hasConceptScore W2597831489C2780943621 @default.
- W2597831489 hasConceptScore W2597831489C502942594 @default.
- W2597831489 hasConceptScore W2597831489C54355233 @default.
- W2597831489 hasConceptScore W2597831489C55493867 @default.
- W2597831489 hasConceptScore W2597831489C81885089 @default.